Inappropriate medications – such as oleandrin, a derivative of oleander known to be toxic – used to prevent or treat COVID-19 could cause significant harm and no benefit, University of Arizona Health Sciences-based center and Banner Health center warn.
Bolstered by a $1.6 million grant, Dr. Timothy Bolger, at the University of Arizona Cancer Center, is studying how cells respond to stress and the role this process has in cancer growth and aging.
A University of Arizona Health Sciences cohort study of more than 50,000 menopausal women showed significant decrease in Alzheimer’s disease diagnosis.
Drs. Leslie Farland and Melanie Bell at the UArizona Mel and Enid Zuckerman College of Public Health to lead a federally funded research study to investigate a link among endometriosis, infertility and stroke in women.
Free and open to the public, the livestreamed online lecture by University of Arizona Arthritis Center Director Dr. C. Kent Kwoh will focus on the mechanisms of stem cell and Platelet-Rich Plasma therapies to treat osteoarthritis.
UArizona and Covid Watch Launch COVID-19 Exposure Notification App
Drs. Arka Chatterjee, Talal Moukabary and Madhan Sundaram bring significant expertise in interventional cardiology and electrophysiology to the Sarver Heart Center and Banner – University Medicine Tucson.
A new federal grant ensures the Pediatric Pulmonary Center at the University of Arizona Health Sciences will continue building skills of health-care providers to care for such children and their families.
The University of Arizona’s Dr. Maria Altbach is working with industry to improve MRI detection of liver tumor spread to expand therapeutic options and improve survival of colorectal cancer patients.
University of Arizona pharmacologist Dr. Todd Vanderah discusses how the conditions created by the COVID-19 pandemic and the response could be exacerbating drug use and overdose.
A University of Arizona Cancer Center grant aims to improve colorectal cancer screening in Arizona’s American Indian communities, where screening rates lag behind those for others across the nation.
A $2.8 million grant will fund research to develop an improved therapeutic treatment for acute ischemic stroke patients that may help them recover faster with fewer long-term complications.
Dr. Emmanuel Katsanis is studying a new chemotherapy treatment for patients with blood-related cancers, such as leukemia, who undergo a particular type of bone marrow transplant procedure.
Sarver Heart team led by Khadijah Breathett looking into gender and racial bias found doctors more judgmental on women’s appearance and social support networks, particularly African American women.
Three experts in constitutional law, environmental law and public health write in a new essay that one of America’s founding documents provides a framework for finding common ground to fight COVID-19.
With 19 new companies added to its roster last fiscal year, the University of Arizona has now launched more than 100 startups since revamping its commercialization operation in late 2012.
New findings by University of Arizona College of Medicine – Tucson chemists Drs. Wolfgang Peti and Rebecca Page provide a foundation to better understand and treat these neurological disorders.
With Department of Defense funding, the University of Arizona College of Medicine – Phoenix leads effort to develop portable device to detect biological threats, like the virus that causes COVID-19.
Recent notices include appointments for curricular affairs, licensing, sleep medicine, research and student mental health, plus national awards for mentorship, diversity and pancreatic cancer studies.
The university will offer four class formats and implement a range of safety measures on campus when the fall semester begins on Aug. 24 as scheduled with a mix of in-person and remote instruction.